Chandra Bhagat Pharma Stock Screener | Share Price & Fundamental Analysis
CBPL
Pharmaceuticals
Screen Chandra Bhagat Pharma share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹34.00 Cr.
P/B Ratio
1.13
EPS (TTM)
₹1.14
Dividend Yield
-
Debt to Equity
0.63
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹102.00
Total Equity
₹30.00
Chandra Bhagat Pharma Share Price History - Stock Screener Chart
Screen CBPL historical share price movements with interactive charts. Analyze price trends and patterns.
Chandra Bhagat Pharma Company Profile - Fundamental Screener
Screen Chandra Bhagat Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CBPL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE07QQ01016
Chandra Bhagat Pharma Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen CBPL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 102 | 102 | 61 | 73 | 72 | 75 | 83 |
| Current Assets | 98 | 98 | 58 | 71 | 70 | 73 | 81 |
| Fixed Assets | 3 | 3 | 1 | 1 | 0 | 0 | 1 |
| Liabilities | |||||||
| Total Liabilities | 102 | 102 | 61 | 73 | 72 | 75 | 83 |
| Current Liabilities | 2 | 2 | 6 | 8 | 13 | 15 | 16 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 30 | 29 | 28 | 27 | 26 | 26 | 14 |
| Share Capital | 8 | 8 | 8 | 8 | 8 | 8 | 1 |
| Reserves & Surplus | 22 | 22 | 20 | 19 | 18 | 18 | 14 |
Screen CBPL income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 92 | 233 | 120 | 96 | 71 | 94 | 107 |
| Expenses | 0 | 88 | 228 | 116 | 91 | 67 | 91 | 102 |
| EBITDA | 0 | 4 | 4 | 4 | 4 | 4 | 4 | 5 |
| Operating Profit % | 0.00% | -2.00% | -3.00% | 3.00% | 3.00% | 5.00% | 3.00% | 4.00% |
| Depreciation | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 2 | 1 | 2 | 3 | 4 | 3 | 4 |
| Profit Before Tax | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 1 |
| Tax | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 2 | 1 | 1 | 0 | 0 | 1 |
| EPS | 0.00 | 1.14 | 2.03 | 1.20 | 1.06 | 0.25 | 0.55 | 13.38 |
Chandra Bhagat Pharma Cash Flow Screener - Liquidity Fundamentals
Screen CBPL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -6 | 6 | 5 | 12 | 8 | -7 | 4 | -6 | -9 | 0 |
| Investing Activities | -1 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 2 | -6 | -4 | -10 | -6 | 7 | -4 | 7 | 8 | 0 |
| Net Cash Flow | -5 | -2 | 1 | 3 | 2 | 0 | 0 | 0 | -1 | 0 |
Screen CBPL shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Mar | 2023-Sept | 2022-Mar | 2022-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.20% | 72.19% | 68.77% | 69.29% | 68.24% | 68.69% | 70.11% | 69.09% |
| FII Holding | 0.61% | 0.61% | 1.33% | 0.48% | 0.00% | 1.33% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.89% | 0.00% | 0.00% | 0.89% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 11.16% | 11.84% | 16.92% | 12.84% | 18.98% | 17.07% | 17.79% | 18.97% |
| Other Holding | 17.03% | 15.36% | 12.09% | 17.39% | 12.78% | 12.02% | 12.10% | 11.94% |
| Shareholder Count | 316 | 301 | 152 | 315 | 146 | 134 | 126 | 126 |
Chandra Bhagat Pharma Dividend Screener - Share Yield Analysis
Screen CBPL dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Chandra Bhagat Pharma Index Membership - Market Screener Classification
Screen CBPL by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Chandra Bhagat Pharma Market Events Screener - Corporate Actions
Screen CBPL market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.31% | ||
| Annual General Meeting | NA | -2.27% | ||
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 0.00% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 2.11% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | 2.13% |
Chandra Bhagat Pharma Competitors Screener - Peer Comparison
Screen CBPL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Chandra Bhagat Pharma Company Announcements - News Screener
Screen CBPL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-13 | Un-Audited Result For Half Year Ended September 30 2025. | View |
| 2025-11-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On 13Th November 2025 For Approval Of Un-Audited Result As On 30.09.2025 | View |
| 2025-11-07 | Board Meeting Intimation for For Approval Of Un-Audited Result For The Half Year Ended 30Th September 2025 | View |
| 2025-10-20 | Disclosure | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-06 | Notice Of Shareholders Meeting Held On September 30 2025. | View |
| 2025-09-06 | Board Meeting Outcome for Outcome Of The Board Meeting Held On September 062025. | View |
| 2025-05-29 | Appointment Of Secretarial Auditor. | View |
| 2025-05-29 | Result For The Financial Year March 31 2025. | View |
| 2025-05-29 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-05-24 | Board Meeting Intimation for Approval Of Audited Financial Statement As On March 31 2025. | View |
| 2025-04-21 | General-Updates | View |
| 2025-03-31 | Closure of Trading Window | View |
| 2025-01-21 | Non-Applicability Of Compliance Governance Report. | View |
| 2024-11-13 | Result For The Half Year Ended As On September 30, 2024. | View |
| 2024-11-13 | Board Meeting Outcome for Outcome Of Board Meeting Be Held On November 13, 2024. | View |
| 2024-11-07 | Board Meeting Intimation for Approval Of Unaudited Result For The Half Year Ended As On September 30, 2024 | View |